Director, Global Marketing

Director of Solid Tumor Global Marketing

At Genmab, we are dedicated to building extraordinary futures, together, by developing antibody products and groundbreaking antibody medicines that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals' unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.

Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.

Does this inspire you and feel like a fit? Then we would love to have you join us!

The Director of Solid Tumor Global Marketing, reporting to the VP, Global Brand Lead for Solid Tumors, Global Marketing, will support the global marketing efforts for Genmab's late stage solid tumor portfolio, with a focus on Solid Tumors, including HNSCC and CRC settings. The successful candidate will possess a blend of strategic thinking, leadership skills and adaptability to global markets. This role demands an individual who has demonstrated success in cross-functional collaboration, implementation, and detailed execution. The Director will build and implement global marketing plans, develop the foundational brand strategy elements, and define the market entry strategy for products in late-stage development.

Responsibilities:

• Implement core aspects of the Global Commercialization Strategy in line with the compound development strategy that ensures successful product launch and uptake across global markets.
• Responsible for coordinating with regional and development teams to ensure a cross-functionally aligned strategy, specifically relating to: global brand plan (definition of lead and follow-on markets, where to play and how to win), global value and access dossier and pricing strategy, LRP / forecast
• Develop brand positioning, market segmentation, and targeting strategies to optimize product launch and lifecycle management.
• Responsible to develop and socialize deep disease area ecosystem understanding (TPP benchmarks, patient flow, patient journey, current and emerging competitive landscape, and future access landscape)
• Responsible to create market development initiatives including unbranded disease area & MOA education, stakeholder relationships
• Development of brand name and identity, customer segmentation, global positioning and message platform
• Direct the analysis of the business; oversee the identification of key segments, business drivers, priorities, and growth opportunities
• Collaborates with Regional markets to ensure synchronized efforts on creation of regionally led marketing initiatives and promotional strategy
• Assists in managing the marketing budget ensuring effective allocation of resources

Qualifications:

• Bachelor's degree required; advanced degree preferred.
• 10+ years of experience in pharmaceutical or biotech marketing, with a focus on oncology, solid tumors required.
• Strong analytical skills and strategic thinking, with the ability to translate complex scientific information into compelling commercial strategies.
• Demonstrated success in developing and implementing global marketing strategies for oncology products.
• Strong leadership and communication skills.
• Team management.
• Comfortable working in a fast-paced, dynamic environment, and capable of making decisions amidst uncertainty.
• A collaborative mindset and the ability to work effectively across functions and regions to achieve shared goals.

Requirements:

• Exceptional ability to analyze market insights and integrate them into effective brand and commercial strategies.
• Proven leadership skills, capable of matrix management and influencing without direct authority; exceptional communication skills are essential.
• Create and execute market entry and brand strategy for new oncology products, focusing on gynecological tumors.
• Foster relationships with key opinion leaders, patient advocacy groups, and professional societies to enhance brand visibility and support.
• Demonstrated success in pre-launch and launch phases of oncology products, with a deep understanding of the solid tumor landscape.
• Resourceful, decisive, and proactive approach to managing multiple priorities in a fast-growing organization.
• Travel – 25%

Location: This position currently adopts a hybrid work model, requiring 3 days per week on-site at the Princeton, NJ office.

For US based candidates, the proposed salary band for this position is as follows:

$205,632.00---$308,448.00

The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location. Also, certain positions are eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives.

When you join Genmab, you're joining a culture that supports your physical, financial, social, and emotional wellness. Within the first year, regular full-time U.S. employees are eligible for:

• 401(k) Plan: 100% match on the first 6% of contributions
• Health Benefits: Two medical plan options (including HDHP with HSA), dental, and vision insurance
• Voluntary Plans: Critical illness, accident, and hospital indemnity insurance
• Time Off: Paid vacation, sick leave, holidays, and 12 weeks of discretionary paid parental leave
• Support Resources: Access to child and adult backup care, family support programs, financial wellness tools, and emotional well-being support
• Additional Perks: Commuter benefits, tuition reimbursement, and a Lifestyle Spending Account for wellness and personal expenses

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab's vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific.